Two Different Schedules of Palbociclib + Second Line Endocrine Therapy in Estrogen Receptor Positive, HER2 Neg Advanced/Metastatic Breast Cancer
Canadian Cancer Trials Group
Canadian Cancer Trials Group
Pfizer
Dana-Farber Cancer Institute
Novartis
Pfizer
Pfizer
City of Hope Medical Center
Hoffmann-La Roche
MedImmune LLC
Monash University
Hellenic Breast Surgeons Society
Virginia Commonwealth University
National Cancer Institute (NCI)
University of Wisconsin, Madison